← Back
$ALLO All transactions

Allogene Therapeutics, Inc.

A

$ Value

$0

Shares

94,500

Price

$0

Filed

Jun 23

Insider

Name

Kazam Joshua A

Title

CIK

0001221355

Roles

Director

Transaction Details

Transaction Date

2025-06-18

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

94,500

Footnotes

Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in two successive equal semi-annual installments over the one-year period measured from the date of grant, subject to continued service through the vesting date.

Filing Info

Accession No.

0001737287-25-000071

Form Type

4

Issuer CIK

0001737287

Kazam Joshua A's History

Date Ticker Type Value
2025-12-18 ALLO M $0
2025-12-18 ALLO M $0
2025-06-20 KRON U $54K
2025-06-20 KRON D $0
2025-06-20 KRON D $0
2025-06-20 KRON D $0
2025-06-20 KRON D $0
2025-06-18 ALLO A $0

Other Insiders at ALLO (90d)

Insider Bought Sold Last
Belldegrun Arie 2026-02-02
Douglas Earl Martin
SVP, General Counsel
$40K 2026-02-02
Parker Geoffrey M.
CHIEF FINANCIAL OFFICER
$42K 2026-02-02
Chang David D
President and CEO
$171K 2026-02-02
Yoshiyama Annie
SVP, Finance
$29K 2026-04-21
Roberts Zachary
EVP of R&D
$63K 2026-02-02
Beneski Benjamin Machinas
SVP, Chief Technical Officer
$20K 2026-03-31